Why is Astec Lifescienc falling/rising?

As of 13-Aug, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at 800.00, which reflects a decrease of 22.0 points or 2.68%. The stock has underperformed its sector today by 1.72%, with an intraday high of Rs 846.15 and a low of Rs 797.5. Over the past week, the stock has seen a return of -5.73%, and it has consistently underperformed against the benchmark, with a year-to-date return of -20.40% compared to the Sensex's gain of 3.07%. The company has reported negative results for the last five consecutive quarters, with significant operating losses and a high debt-to-EBITDA ratio of 2.64 times, indicating weak long-term fundamental strength and low profitability.
Broader Market Context: In the context of the broader market, Astec Lifesciences has shown a consistent underperformance against the benchmark indices over the past three years, with a staggering decline of -58.05% compared to the Sensex's growth of 35.45%. This stark contrast highlights the challenges the company faces, particularly in light of its negative EBITDA and declining profits, which have fallen by -63.3% over the past year. The overall market sentiment appears to be cautious, as reflected in the stock's liquidity and trading volume, suggesting that investors are wary of the company's financial health and future prospects.